Five Lessons Learned From Randomized Controlled Trials on Mobile Health Interventions: Consensus Procedure on Practical Recommendations for Sustainable Research.


Journal

JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439

Informations de publication

Date de publication:
08 02 2021
Historique:
received: 24 05 2020
accepted: 07 12 2020
revised: 22 09 2020
entrez: 8 2 2021
pubmed: 9 2 2021
medline: 30 4 2021
Statut: epublish

Résumé

Clinical research on mobile health (mHealth) interventions is too slow in comparison to the rapid speed of technological advances, thereby impeding sustainable research and evidence-based implementation of mHealth interventions. We aimed to establish practical lessons from the experience of our working group, which might accelerate the development of future mHealth interventions and their evaluation by randomized controlled trials (RCTs). This paper is based on group and expert discussions, and focuses on the researchers' perspectives after four RCTs on mHealth interventions for chronic pain. The following five lessons are presented, which are based on practical application, increase of speed, and sustainability: (1) explore stakeholder opinions, (2) develop the mHealth app and trial simultaneously, (3) minimize complexity, (4) manage necessary resources, and (5) apply behavior change techniques. The five lessons developed may lead toward an agile research environment. Agility might be the key factor in the development and research process of a potentially sustainable and evidence-based mHealth intervention.

Sections du résumé

BACKGROUND
Clinical research on mobile health (mHealth) interventions is too slow in comparison to the rapid speed of technological advances, thereby impeding sustainable research and evidence-based implementation of mHealth interventions.
OBJECTIVE
We aimed to establish practical lessons from the experience of our working group, which might accelerate the development of future mHealth interventions and their evaluation by randomized controlled trials (RCTs).
METHODS
This paper is based on group and expert discussions, and focuses on the researchers' perspectives after four RCTs on mHealth interventions for chronic pain.
RESULTS
The following five lessons are presented, which are based on practical application, increase of speed, and sustainability: (1) explore stakeholder opinions, (2) develop the mHealth app and trial simultaneously, (3) minimize complexity, (4) manage necessary resources, and (5) apply behavior change techniques.
CONCLUSIONS
The five lessons developed may lead toward an agile research environment. Agility might be the key factor in the development and research process of a potentially sustainable and evidence-based mHealth intervention.

Identifiants

pubmed: 33555263
pii: v9i2e20630
doi: 10.2196/20630
pmc: PMC7899803
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e20630

Informations de copyright

©Daniel Pach, Alizé A Rogge, Jiani Wang, Claudia M Witt. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 08.02.2021.

Références

Malawi Med J. 2019 Sep;31(3):177-183
pubmed: 31839886
JMIR Mhealth Uhealth. 2018 Jan 09;6(1):e7
pubmed: 29317380
Am J Obstet Gynecol. 2018 Feb;218(2):227.e1-227.e9
pubmed: 29155036
J Med Internet Res. 2018 Nov 23;20(11):e10971
pubmed: 30470678
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
Comput Inform Nurs. 2006 Mar-Apr;24(2):75-82; quiz 83-4
pubmed: 16554690
JMIR Mhealth Uhealth. 2019 Jul 04;7(7):e11926
pubmed: 31274112
JMIR Mhealth Uhealth. 2015 Aug 19;3(3):e82
pubmed: 26290327
BMJ. 2016 Mar 17;352:i1174
pubmed: 26988021
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
Adm Policy Ment Health. 2015 Mar;42(2):157-67
pubmed: 24824311
Stud Health Technol Inform. 2013;192:657-61
pubmed: 23920638
JMIR Mhealth Uhealth. 2020 Feb 11;8(2):e14661
pubmed: 32058976
JMIR Mhealth Uhealth. 2018 Jan 17;6(1):e23
pubmed: 29343463
Implement Sci. 2011 Feb 07;6:10
pubmed: 21299860
Eval Program Plann. 2006 Nov;29(4):397-404
pubmed: 17950868
Evid Based Complement Alternat Med. 2014;2014:561320
pubmed: 24648848
Trials. 2013 Apr 11;14:99
pubmed: 24499425
Psychiatry Investig. 2019 Feb;16(2):97-98
pubmed: 30808114
JMIR Mhealth Uhealth. 2019 Dec 20;7(12):e15707
pubmed: 31859680
Trials. 2014 Dec 15;15:490
pubmed: 25511185

Auteurs

Daniel Pach (D)

Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Institute for Complementary and Integrative Medicine, University of Zurich and University Hospital Zurich, Zurich, Switzerland.

Alizé A Rogge (AA)

Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Department of Psychosomatic Medicine, Center for Internal Medicine and Dermatology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Jiani Wang (J)

Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Claudia M Witt (CM)

Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Institute for Complementary and Integrative Medicine, University of Zurich and University Hospital Zurich, Zurich, Switzerland.
Center for Integrative Medicine, University of Maryland School of Medicine, Baltimore, MD, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH